Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
June 17, 2007
Drug Sales Predicted to Double to $1.3 Trillion by 2020 | www.therapeuticsdaily.com
Trends are showing up signalling a change in FDA posture regarding RX drugs going OTC. If this trend keeps going, the 1.3 trillion predicted for drug sales might be a tad higher. Our FDA is starting to resemble European standards as far as looking the other way.
Are we compromising the immune system?
March 2, 2007
FDA Approves Abbott's Humira for Treatment of Crohn's Disease | online.wsj.com
The annoying life style symptoms that accompany this drug, Humira, may only be tolerated if the disease is totally debilitating the patient.
The persistent cough and flu like symptoms I see my arthritis patients exhibiting, are tough to live with.
Helps Eczema, does little for Psoriasis
January 31, 2007
Stiefel Laboratories Receives FDA Approval of Olux-E (Clobetasol Propionate) Foam, 0.05% for Treatment of Psoriasis and Eczema | pharmalive.com
As a Compounding Pharmacist, I used Clobetasol Propionate alone, and in combination with other ingredients. It controlled the patient's eczema, but when it came to psoriasis, it did very little. In my 45 years as a Pharmacist, I have yet to have good results treating psoriasis, a condition that goes back to the beginning of time.
Page : 11 to 3 of 3
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011